Top View
- January 2017 TABLE of CONTENTS
- Product List
- Novel Pharmacological Targets for the Treatment of Parkinson's Disease
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- Levodopa-Induced-Dyskinesias Clinical Features, Incidence, Risk Factors, Management and Impact on Quality of Life
- Development of Novel Serotonin 5-HT6 and Dopamine D2 Receptor
- Rodrigo Quian Quiroga Charalampos Tzoulis, Laurence a Bindoff Helen
- Actions of Novel Antipsychotic Agents on Apomorphine-Induced
- Customs Tariff - Schedule Xxi - 1
- Systematic Review of Interventions for Treating Or Preventing Antipsychotic-Induced Tardive Dyskinesia
- Systematic Review of Interventions for Treating Or Preventing Antipsychotic-Induced Tardive Dyskinesia
- 2. Serotonin 5-HT1A Receptor Signalling: G-Protein Activation
- Human Neurogenesis Assay: Ramelteon
- 5-HT Receptor Serotonin Receptor; 5-Hydroxytryptamine Receptor
- Parkinson's Disease in Romania
- (12) United States Patent (10) Patent No.: US 8,889,740 B1 Went Et Al
- Journal of Neurology and Experimental Neural Science Guertin AP
- Neurogenesis Via Modulation of the Muscarinic Receptors
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Predictive Value of Parkinsonian Primates in Pharmacologic Studies: a Comparison Between the Macaque, Marmoset, and Squirrel Monkey S
- Deep Brain Stimulation of the Subthalamic and Entopeduncular Nuclei in an Animal Model of Tardive Dyskinesia
- (12) United States Patent (10) Patent No.: US 7,678,808 B2 Barlow Et Al
- Antidepressant-Like Properties of Intrastriatal Botulinum Neurotoxin-A Injection in a Unilateral 6-OHDA Rat Model of Parkinson’S Disease
- Serotonin and Parkinson's Disease
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Non-Dopaminergic Alterations in Depression-Like FSL Rats in Experimental Parkinsonism and L-DOPA Responses
- Studies Describing Baseline Dialysate Concentrations for Asparagine
- L-DOPA/Sarizotan Autoradiography in Striatum Unilateral 6-OHDA (10/2.5 Mg/Kg)
- Sarizotan for Respiratory Symptoms Associated Rett Syndrome NIHRIO (HSRIC) ID: 11805 NICE ID: 9694
- The Multimodal Serotonergic Agent Vilazodone Inhibits L-DOPA
- Universitat Jaume I Department De Psicologia Bàsica, Clínica I
- Emerging Therapies for Parkinson's Disease
- Repurposing Drugs to Treat L-DOPA-Induced Dyskinesia in Parkinson's Disease
- Dopamine Receptor
- Serotonin-And-Parkinson.Pdf
- Development of an Internalisation Assay for G Protein Coupled
- Clinical Management of Drug-Induced Dyskinesia in Parkinson's Disease
- Parkinson's Disease
- Veyres N, Hamadjida A, Huot P. Predictive Value of Parkinsonian Primates in Pharmacological Studies, a Comparison Between the Macaque, Marmoset and Squirrel Monkey